Poland· PL-100544119
Femoston
A dydrogesteron und estrogen product containing estradiolum, estradiolum + dydrogesteronum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dydrogesteron und estrogen is registered in 9 of 19 countries.
Countries holding a registration under ATC G03FB08 (dydrogesteron und estrogen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Dydrogesteron und estrogen · ATC G03FB08
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Estradiolum, Estradiolum + Dydrogesteronum
- Manufacturer
- Medezin Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G03FB08
- ATC class
- Dydrogesteron und Estrogen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991607685
- gtin05909991607692
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for dydrogesteron und estrogen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dydrogesteron und estrogen · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under G03FB08
Dydrogesteron und estrogen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fdc70d13-4610-45eb-841a-cf8123929b55 GET /v1/drugs/fdc70d13-4610-45eb-841a-cf8123929b55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "2 mg (ceglastoczerwone), 2 mg + 10 mg (żółte)",
"packaging": "05909991607685 ¦ Rp ¦ 168155\n28 tabl.\n05909991607692 ¦ Rp ¦ 168156\n84 tabl.",
"substance": "Estradiolum, Estradiolum + Dydrogesteronum 2 mg (ceglastoczerwone), 2 mg + 10 mg (żółte)",
"common_name": "Estradiolum, Estradiolum + Dydrogesteronum",
"pl_product_id": "100544119",
"pozwolenie_nr": "294/26",
"auth_procedure": "IR",
"authorisation_validity": "2031-08-10"
}See everything about dydrogesteron und estrogen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.